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Background: The lack of a reliable scoring system that predicts the development of septic shock and death
precludes comparison of disease and/or treatment outcomes in animal models of sepsis. We developed a murine
sepsis score (MSS) that evaluates seven clinical variables, and sought to assess its validity and reliability in an
experimental mouse model of polymicrobial sepsis.
Methods: Stool collected from the cecum of C57BL/6 (B6) mice was dissolved in 0.9% normal saline (NS) and
filtered, resulting in a fecal solution (FS) which was injected intraperitoneally into B6 mice. Disease severity was
monitored by MSS during the experimental timeline. Blood and tissue samples were harvested for the evaluation of
inflammatory changes after sepsis induction. The correlation between pro-inflammatory markers and MSS was
assessed by the Spearman rank correlation coefficient.
Results: Mice injected with FS at a concentration of 90 mg/mL developed polymicrobial sepsis with a 75% mortality
rate at 24 hours. The MSS was highly predictive of sepsis progression and mortality, with excellent discriminatory
power, high internal consistency (Cronbach alpha coefficient = 0.92), and excellent inter-rater reliability (intra-class
coefficient = 0.96). An MSS of 3 had a specificity of 100% for predicting onset of septic shock and death within 24 hours.
Hepatic dysfunction and systemic pro-inflammatory responses were confirmed by biochemical and cytokine analyses
where the latter correlated well with the MSS. Significant bacterial dissemination was noted in multiple organs.
Furthermore, the liver, spleen, and intestine demonstrated histopathological evidence of injury.
Conclusions: The MSS reliably predicts disease progression and mortality in an animal model of polymicrobial sepsis.
More importantly, it may be used to assess and compare outcomes among various experimental models of sepsis, and
serve as an ethically acceptable alternative to death as an endpoint.
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Sepsis remains one of the leading causes of death in non-
coronary intensive care units (ICUs) [1,2], with a mortality
rate of approximately 30% despite optimal therapeutic
intervention. Moreover, the mortality rate rises up to 70%
[2,3] when there is ongoing organ dysfunction or severe
sepsis [4]. Close to two million cases of sepsis are identi-
fied annually worldwide, although this figure may be a* Correspondence: tina.mele@lhsc.on.ca
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unless otherwise stated.gross underestimation because of inadequate diagnosis
[3]. Defined as an overwhelming and dysregulated inflam-
matory response that is often initiated by infection, sepsis
disrupts the cardiovascular, immunological, and endocrine
systems in a complex, patient- and organism-specific
manner, making it difficult to study this disease clinically.
Animal models that attempt to mimic the complexities of
sepsis in the laboratory setting have yielded new insights
into the pathophysiology and molecular mechanisms of
this illness. However, the failure of therapies that showed
promise during the preclinical stages, but yielded little
benefit in human trials [5,6], have led to renewed calls for
a closer examination into the shortcomings of conven-
tional animal models of sepsis [5,7].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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microbial-based responses which may be mono- or poly-
microbial in design. Using a single organism results in a
septic state that is dependent on the type and amount
used as well as the animal and route of administration [8],
whereas a polymicrobial model typically mimics intra-
abdominal sepsis, which affects 20% of patients admitted
with sepsis [9]. Polymicrobial models of sepsis typically in-
volve either fecal-induced peritonitis (FIP) or cecal ligation
and puncture (CLP). In the FIP model, a freshly prepared
fecal solution is derived from murine colonic stool and
injected intraperitoneally into mice at a defined concen-
tration to result in acute peritonitis. In the CLP model, the
cecum is ligated in a non-obstructing manner, and punc-
tured to allow fecal content to leak into the normally ster-
ile peritoneal cavity [10]; a mixed bacterial infection with
an inflammatory source of necrotic intestinal tissue is
subsequently established [11-13]. Irrespective of the model
used to induce and evaluate sepsis, however, the paucity of
reliable validated scoring systems that can be applied to an-
imals severely limits comparison of disease outcomes and
treatment regimens across different experimental models
of sepsis. Given that sophisticated scoring systems, such
as the Acute Physiology and Chronic Health Evaluation
(APACHE) II, Simplified Acute Physiology Score (SAPS) II,
and Sequential Organ Failure Assessment (SOFA) score,
can evaluate the degree of critical illness and provide prog-
nostic clarity for patients with sepsis [14], the development
of similar metrics for animal models would allow for the
consistent and standardized reporting of disease severity
and therapeutic outcomes. A pioneering study by Huet
and colleagues [15] demonstrated that a mouse clinical as-
sessment score for sepsis (M-CASS) provided a consistent
and objective evaluation of disease severity in a mouse
model of Klebsiella pneumonia-induced pneumonia, with
high reliability and reproducibility. Eight criteria (fur as-
pect, activity, posture, behaviour, respiration, chest sounds,
eyes, and body weight) were assessed to provide an overall
score between 1 and 4, which subsequently dictated the
frequency of further monitoring and/or euthanasia. In our
present study, we independently developed and validated a
murine sepsis score (MSS) which evaluates seven individ-
ual criteria, and results in an aggregate score to evaluate
the clinical condition of mice with experimental polymi-
crobial sepsis. Furthermore, we assessed the specificity and
sensitivity of the MSS for predicting the onset of severe
sepsis and death in a mouse model of FIP, and evaluated its




Male C57BL/6 mice, 10–12 weeks of age, were pur-
chased from Charles River Laboratories International, Inc.(Wilmington, MA) and placed in standard housing in the
Health Sciences Animal Care Facility at Western University
(London, ON, Canada). Animals had an average weight
of 22.5 g (range, 21–25 g) prior to the start of the exper-
iments. Animal husbandry conditions included a room
temperature of 23°C, humidity of 50%, and a 12-hour
light–dark cycle (dark from 1900 h to 0700 h). Bedding
in cages consisted of sawdust and wood shavings, while
corn mash and water (in a stoppered-bottle with a nose-
activated nozzle) was available for mice to feed ad lib.
Cages also contained an igloo to allow nesting. Animals
were housed with one to three cage mates. All animal
procedures were done in accordance with guidelines set
by the Canadian Council on Animal Care and approval
was granted by the Western University Animal Use
Subcommittee (no. 2008–034).
Sepsis model
Preparation of fecal slurry
The solution used to cause FIP was made by the follow-
ing procedure: fresh feces were collected from the lower
cecum of euthanized donor mice, weighed, and mixed
with a calculated volume of saline solution to give fecal
concentrations of 45, 90, and 180 mg/mL. To ensure re-
producibility, the procedure was standardized by the
use of fresh solution prepared from mice living in the
same conditions as the experimental animals. The solu-
tion was pressed through a 70-μm nylon mesh strainer
(BD Biosciences, Franklin, NJ) to remove particulate
matter.
Induction of sepsis
For sepsis induction, each mouse was given an intra-
peritoneal (i.p.) injection of 0.5 mL of the fecal slurry
solution using a syringe and 27G needle. Depending on
the fecal concentrations (45, 90, and 180 mg/mL) used,
each mouse therefore received 2, 4, or 8 mg of FIP solu-
tion per 1 g body weight respectively. Sham mice were
injected with sterile normal saline (NS). Pain (either
from the injection or from the fecal slurry)was assessed
using facial expression as described by Langford et al.
[16], as well as body posture and vocalization. Analgesia
was provided by a subcutaneous injection of buprenor-
phine (0.1 mg/kg).
Monitoring of mice
Monitoring of the health of the animals was conducted by
two investigators every 2 hours after the induction of sep-
sis for 12 hours, and then every hour thereafter: one of the
investigators was blinded to the treatment so as to test for
the reproducibility of the MSS. Mice were evaluated while
they were still in their cages (with the lids removed for
better visualization).
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In a pilot study involving thirty mice that were given
90 mg/mL fecal slurry and observed over 24 hours, a
veterinarian from the Animal Care and Veterinary Ser-
vices (ACVS, Western University) and the primary au-
thor of this study (Shrum) assessed the mice jointly
using variables that have been described in the literature
[8,15,16]. Certain variables such as temperature and weight
loss did not change during the experimental timeline, whileTable 1 Murine Sepsis Score (MSS) to assess the severity of d
peritonitis
Variable Score and descriptio
Appearance 0- Coat is smooth
1- Patches of hair pilo
2- Majority of back is
3- Piloerection may o
4- Piloerection may o
Level of consciousness 0- Mouse is active
1- Mouse is active bu
2- Mouse activity is no
3- Activity is impaired
4- Activity severely im
Activity 0- Normal amount of
1- Slightly suppressed
2- Suppressed activity
3- No activity. Mouse
4- No activity. Mouse
Response to stimulus 0- Mouse responds im
1- Slow or no respons
2- No response to aud
3- No response to aud
4- No response to audi
Eyes 0- Open
1- Eyes not fully open
2- Eyes at least half cl
3- Eyes half closed or
4- Eyes closed or milk
Respiration rate 0- Normal, rapid mou
1- Slightly decreased
2- Moderately reduce
3- Severely reduced re
4- Extremely reduced
Respiration quality 0- Normal
1- Brief periods of lab
2- Laboured, no gasp
3- Laboured with inte
4- Gaspingfewer than 5 % of mice needed analgesia for pain immedi-
ately after the fecal slurry injection. Consequently, the final
variables that were incorporated into the MSS (Table 1) in-
cluded spontaneous activity, response to touch and audi-
tory stimuli, posture, respiration rate and quality (laboured
breathing or gasping), and appearance (i.e. degree of piloer-
ection). Each of these variables are given a score between 0
and 4, and are detailed in Table 1. Mice were euthanized if




r may not be present, mouse appears “puffy”
r may not be present, mouse appears emaciated
t avoids standing upright
ticeably slowed. The mouse is still ambulant.
. Mouse only moves when provoked, movements have a tremor
paired. Mouse remains stationary when provoked, with possible tremor
activity. Mouse is any of: eating, drinking, climbing, running, fighting
activity. Mouse is moving around bottom of cage
. Mouse is stationary with occasional investigative movements
is stationary
experiencing tremors, particularly in the hind legs
mediately to auditory stimulus or touch
e to auditory stimulus; strong response to touch (moves to escape)
itory stimulus; moderate response to touch (moves a few steps)
itory stimulus; mild response to touch (no locomotion)
tory stimulus. Little or no response to touch. Cannot right itself if pushed over
, possibly with secretions
osed, possibly with secretions
more, possibly with secretions
y
se respiration
respiration (rate not quantifiable by eye)
d respiration (rate at the upper range of quantifying by eye)
spiration (rate easily countable by eye, 0.5 s between breaths)
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by more than 3.
Euthanasia of mice
At the conclusion of the experiments, animals were sacri-
ficed and post-mortem laparotomy was performed in order
to collect tissues. Mice were anesthetized with 100 mg/kg
ketamine (Bioniche Life Sciences, Belleville, ON) and
5 mg/kg xylazine (Bayer AG, Leverkusen, Germany), and
euthanized by cardiac puncture using a 27G needle and
3-mL syringe.
Blood and tissue collection and CFU determination
Blood collected from the cardiac puncture of mice dur-
ing euthanasia was centrifuged to separate the serum,
which was stored at -80°C until use for biochemistry as-
says and cytokine analysis. The liver, spleen, kidneys,
heart, lungs, lower intestine and brain were fixed in buff-
ered 4% formalin, embedded in paraffin, and used for
hematoxylin and eosin (H&E) staining. In separate ex-
periments, tissues were collected for homogenization
and plating on brain heart infusion (BHI) agar media for
overnight growth in an aerobic chamber at 37°C to de-
termine the number of bacterial colony-forming units
(CFUs) per organ [17].
Histopathology
Tissues were harvested and fixed using 4% formaldehyde.
Tissues were then embedded using paraffin and serially
sectioned (4-μm) in toto. Every third slide was stained with
H&E for histopathological analysis. Two images per slide
were captured with a microscope (Motic B1; Houston, TX)
at a magnification of 20× and at a resolution of 1098 ×
768 pixels. A pathologist (Dr. Aaron Haig, Department of
Pathology, Western University), who was blinded to the
experimental conditions, examined the tissue sections.
Terminal deoxynucleotidyltransferasedUTP nick end
labelling (TUNEL) assay
This procedure was performed as described previously
[18]. Briefly, 4-μm sections were deparaffinized in xylene,
rehydrated in graded alcohol, and rinsed in distilled water.
Antigen unmasking was accomplished using freshly pre-
pared Proteinase K solution (10 μg/mL) for 60 min at 37°C.
After washing twice with distilled water, sections were
incubated with TdT enzyme (75 U/mL; EMD Millipore
Corp., Billarica, MA) and digoxigenin-11-UTP (5 nmol)
for 90 min at 37°C. The slides were then washed in SSC
buffer (150 mmolNaCL, 15 mmol sodium citrate, pH 7.0),
followed by Tris–HCl buffer (10 mmolTris, 150 mmol-
NaCl, pH 8.2) for 1 min per wash. A blocking agent was
used to prevent non-specific binding, and sections were
developed with a Fab fragment against digoxigenin linkedto alkaline phosphatase and fast red chromogen. Sections
were then washed and counter stained.
Serum biochemistry assays
Serum levels of alanine aminotransferase (ALT), aspartate
aminotransferase (AST), and lipase, expressed as U/L, as
well as creatinine (expressed as mg/dL), glucose (mg/dL),
and albumin (mg/dL) were measured using a commer-
cially available diagnostic kit (Catachem Inc., Oxford, CT)
according to the manufacturer’s instructions.
Multiplex cytokine array
Serum was analyzed by bead-based multiplex assay for
32 different cytokines, chemokines, and growth factors
(Eve Technologies, Calgary, Alberta, Canada) including
granulocyte-colony stimulating factor (G-CSF), granulo-
cyte macrophage-colony stimulating factor (GM-CSF),
interleukin (IL)-1α, IL-1β, IL-3, IL-4, IL-5, IL-6, IL-7, IL-
10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17A, IP-10,
keratinocyte chemo-attractant (KC), leukemia inhibitory
factor (LIF), monocyte chemotactic protein (MCP)-1,
monocyte-colony stimulating factor (M-CSF), monokine
induced by gamma interferon (MIG), macrophage in-
flammatory protein (MIP)-1α, MIP-1β, MIP-2, Regulated
on Activation, Normal T cell Expressed and Secreted
(RANTES), tumour necrosis factor (TNF)-α, and vascu-
lar endothelial growth factor (VEGF).
Statistical analysis
Data are expressed as mean and SEM. For the MSS,
serum biochemistry, and multiplex cytokine assay, data
from sham animals obtained at all the time points were
pooled and then employed as a common control group
as Friedman’s test indicated no differences over time.
Data obtained at indicated time points from septic animals
were considered independently. Consequently, differences
between groups were analyzed by applying one-way ana-
lysis of variance (ANOVA) followed by Dunn’s pairwise
comparison for post-hoc analysis. For statistical testing of
all other results, differences between groups were analyzed
by ANOVA or Mann–Whitney test. Group sizes reported
for biochemistry data varied over time, reflecting the mor-
tality rate in septic animals. Logarithmic transformation of
bacterial counts was performed for analysis of bacterial
burden in tissues. In all analyses, two-tailed p values less
than 0.05 were considered statistically significant.
Each of the seven variables measured as part of the
MSS consists of five possible scores (0 to 4). The in-
ternal consistency of the MSS and each of the variables
was assessed by Cronbach’s alpha. Inter-rater reliability
of the MSS was also assessed by calculating the intra-
class coefficient (ICC), comparing each assessor’s inde-
pendent scores for each mouse (sham and septic) at 2, 12,
14, 16, 18, 20, and 24 hours. Additionally, the ability of the
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tested using the receiver operating characteristic (ROC)
curve, and by quantifying the area under the curve (AUC)
[19]. An AUC between 0.7 and 0.8 is classified as “accept-
able,” and an AUC between 0.8 and 0.9 is considered to
have an “excellent” discrimination [19]. For the MSS, the
score giving the best Youden index was determined to be
the cutoff point [20]: the sensitivity, specificity, and posi-
tive and negative predictive values were calculated based
on this score.
To ensure that the MSS reflected the severity of the septic
insult, correlations between the sepsis score and serum pro-
inflammatory cytokine levels were performed by calculating
the Spearman rank correlation coefficient (Spearman’s rho).
All data analysis was performed using Graphpad Prism
Version 5.01 (Graphpad, La Jolla, California).
Results
A total of 300 mice were used in the survival experi-
ments that were conducted independently over a period
of two years. Compared to sham-treated mice (n = 60),A
C





































Figure 1 Characterization of the FIP sepsis model in mice. (A) Mouse s
mice per concentration of FS). (B) Murine Sepsis Score (MSS) over time of m
experiment). (C) Viable bacterial colony forming units (CFU) recovered from
euthanasia (n = 5). (D) Receiver-operator curve (ROC) evaluating the sensitiv
those that progress to septic shock and death.which had a survival of 100% throughout the experimental
timeline, FIP mice had a survival rate of 0% for 180 mg/
mL FS (n = 20), 25% for 90 mg/mL FS (n = 200) and 40%
for 45 mg/mL FS (n = 20) at 24 hours post-FIP induction
(Figure 1A). For subsequent experiments, we used a FS
concentration of 90 mg/mL to mimic the clinical mortality
of 70-80% in severe, untreated intra-abdominal sepsis [2,3].
The MSS for FIP mice at a concentration of 90 mg/
mL are shown in Figure 1B. Compared to sham-treated
mice with a mean score of 1 after 24 hours, FIP-treated
mice had significantly higher (p < 0.0001) sepsis scores.
Between 0 to 11 hours post-FIP induction, mouse scores
remained relatively consistent as assessed by independent
observers, with mild piloerection and decreased move-
ment. After 12 hours, septic mice appeared to progres-
sively manifest additional symptoms including decreased
respiratory rate, increasingly laboured breathing and min-
imal response to auditory and tactile stimuli. Between 12
to 17 hours post-FIP induction, variability in sepsis sever-
ity scores was observed to be due to differences in respira-
tory rates and quality of breathing as well as response toD



































urvival over time versus concentration of fecal solution (FS; n = 20
ice that were administered 90 mg/mL FS (n = 20, 1 representative
solid organs of mice treated with 90 mg/mL FS, at the time of
ity and specificity of the MSS in differentiating healthy mice from
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coefficient for comparison between the blinded and
non-blinded assessors of septic mice was 0.96 (95% CI:
0.92 - 0.98), indicating excellent inter-rater reliability.
The Cronbach alpha coefficient was 0.92, indicating ex-
cellent internal consistency of the MSS.
For a concentration of 90 mg/mL FS, we calculated a
mortality rate of 42% within 1 hour of attaining a score
of 10, and a mortality of 75% within 2 hours of attaining
a score of 10. Fifty-seven percent of mice that reached a
score of 15 died or had to be euthanized (in accordance
with guidelines set by the Animal Use Subcommittee)
within 1 hour, and 86% of mice that reached a score of
15 died within 2 hours. Based on the ROC curve gener-
ated for the MSS (Figure 1D), the AUC (95% confidence
interval) was 0.825 (0.752 - 0.898) with a p value < 0.0001,
suggesting that the scoring system has excellent discrimin-
atory power. A MSS of 3 (Youden score of 0.61) was se-
lected as the cut-off point for mice that progressed to
severe sepsis post-FIP induction: the sensitivity (±95% C.I.)
and specificity (±95% C.I.) of this score was 57% (47-67%)
and 100% (82-100%), respectively.
When organs were homogenized and plated on agar,
bacterial growth was observed in all tissues, including
liver, spleen, heart, lung, and kidneys (Figure 1C). Con-
sistent with the polymicrobial nature of the model, sig-
nificant variations in colony size (ranging from 1–3 mm
in diameter), colour (white, brown, and yellow), and CFU
counts were observed. Bacterial counts were not observed
in any organs recovered from sham mice (data not shown).
We did not observe a correlation between sepsis score and
CFU counts in FIP mice.
On necropsy, FIP mice were observed to have developed
diffuse intestinal distension compared to uninfected con-
trol mice (Additional file 1: Figure S1). In addition, FIP
mice had peritoneal and mesenteric lymphadenopathy,
and rarely developed abscesses. We also routinely ob-
served the presence of a yellow fibrin film on the surfaces
of the intra-abdominal organs, most notably overlying the
liver and spleen. We did not identify any grossly visible
areas of necrosis or ischemia within the organs. In mice
that were euthanized due to severe respiratory distress, we
observed minor pulmonary haemorrhage and the lungs
appeared edematous.
Serum biochemistry demonstrated significantly ele-
vated AST and ALT levels in the FIP group at 6, 12, 18,
and 24 hours post-sepsis induction (p < 0.001) compared
to the sham group (Figure 2A). However, both AST and
ALT levels peaked at 6 to 12 hours in septic mice: while
the AST levels declined and rose again at 18 and 24 hours
respectively, the ALT levels fell sharply at 18 and 24 hours.
A linear correlation between liver transaminases and MSS
was only significant for the first 12 hours of the experi-
mental timeline, but was non-significant for the entireduration (24 hours) of the experiment. Serum glucose and
creatinine did not demonstrate significant changes over
time in the FIP group (Figure 2B and C). Serum albumin
levels decreased significantly at 3 and 12 hours post-sepsis
compared to the sham group (p = 0.0057 and p = 0.018, re-
spectively), but there was no difference in albumin levels
after 24 hours (Figure 2D). We observed a trend towards
higher lipase levels at 24 hours post-sepsis but there was
significant variability in lipase activity among individual
mice in the FIP group (Figure 2E).
Histological examination of the tissues demonstrated
different degrees of pathology in various organs at 24 hours
after FIP (Figure 3). In the lung, we observed mild edema
in the alveolar spaces and leukocyte accumulation in the
peripheries of pulmonary arterioles. In the liver of mice
with FIP, parenchymal cells demonstrated vacuolization,
limited necrosis, and loss of organization and structure.
We also occasionally observed capsular edema and recruit-
ment of inflammatory cells onto the liver surface. The
spleen demonstrated significant changes post-sepsis, with
expansion of the white pulp, and widespread cellular
apoptosis, which was also confirmed by TUNEL staining
(Figure 3). At higher concentrations of fecal slurry (180 mg/
mL), pathological changes associated with damage and in-
flammation could be observed within 12 hours of insult
(data not shown). We also observed pathological changes
in the small intestine (Figure 3), characterized by the loss of
goblet cells and loss of villi. We did not observe the accu-
mulation of neutrophils or other leukocytes within the sub-
mucosa, but we occasionally observed necrosis and debris
on the serosal surfaces of the gastrointestinal tract. We did
not observe pathological changes in the hearts or brains of
septic mice at 24 hours (data not shown).
Analysis of cytokine levels by multiplex array showed
a rapid, sustained, and significant increase of the puta-
tive markers of experimental sepsis, namely IL-1β, IL-6,
IL-10, and TNF-α, in FIP mice over a 24-hour period
(p < 0.001) versus the sham group (Figure 4). Addition-
ally, we observed increased levels of eotaxin, M-CSF,
MIG, MIP-1α, MIP-1β, MIP2, IL-5 and IL-15. IL-5 and
IL-15 returned to baseline levels by 12 hours; however,
IL-5 was detected at significantly increased levels at
24 hours, compared to the control group (p < 0.001).
Results of additional analysed cytokines, which are well
described in septic models, are shown in Additional
file 2: Table S1.We also performed a correlation ana-
lysis between serum cytokine levels and the MSS. The
levels of IL-6 (Spearman’s rho = 1.0, p = 0.042), eotaxin
(Spearman’s rho = 1.0, p = 0.042), G-CSF (Spearman’s
rho = 1.0, p = 0.042), M-CSF (Spearman’s rho = 1.0, p =
0.042), MIG (Spearman’s rho = 1.0, p = 0.042), and RAN
TES (Spearman’s rho = 1.0, p = 0.042) demonstrated sig-
nificant correlations with MSS throughout the experimen-
tal timeline.
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Figure 2 Blood serum biochemistry of (A) liver enzymes aspartate transaminase (AST) and alanine aminotransferase (ALT), (B) Glucose,
(C) Creatinine, (D) Albumin, and (E) Lipase (n = 4 in donor group; n = 12 for sham group; n ≥ 4 per group at 3 h, 12 h, and 24 h). Mean
values shown with SEM error bars. *p < 0.05, **p < 0.01, ***p < 0.001.
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The development of a reliable, sensitive, and specific scor-
ing system can effectively facilitate comparison of disease
outcomes and therapeutic regimens [5,7,21] across mul-
tiple models of sepsis, and improve the clinical relevance
of novel diagnostic biomarkers [21]. In this study, we dem-
onstrate a robust and comprehensive scoring system with
high internal consistency, excellent inter-rater reliability,
and high specificity and sensitivity in predicting severe sep-
sis and mortality during the experimental timeline.
The MSS reliably predicts 1-hour and 2-hour mortality
when clinical scores are greater than 10, with excellent
discriminatory capacity. Mice that attained a clinical score
of three had 100% specificity for dying from sepsis during
the experimental timeline. Our scoring system uses easilyobserved mouse behaviours and changes in appearance
that have been identified as important factors in measur-
ing septic morbidity [8]. By identifying predictable changes
in appearance, activity, and responses to stimuli in our FIP
mice, we were able to translate our observations into a
scoring system that could be used to monitor and evaluate
sepsis severity in our animal model.
Few studies have characterized the development of a
sepsis score that can reliably predict mortality in animal
models. Huet and colleagues developed a novel “Mouse
Clinical Assessment Score for Sepsis” (M-CASS) for use in
a mouse model of pneumonia [15]. In the M-CASS scoring
approach, a score between 1 and 4 was given after evalu-
ation of variables such as the degree of piloerection, activ-
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Figure 3 Histology of representative tissues from control and FIP (90 mg/mL) at 24 h developed with TUNEL or haematoxylin and





































































































































































































































Figure 4 Blood serum cytokine and chemokines. Sham and FIP (90 mg/mL) cytokine and chemokine levels (pg/mL) at 3, 12, and 24 h post
FIP induction. Mean serum protein concentrations ± SEM are shown (n = 12 for sham group; n≥ 3 for 3, 12, and 24 h groups). *p < 0.05,
**p < 0.01, ***p < 0.001.
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one score that encompasses all eight variables, the scor-
ing system in our study provides an individual score for
each variable, which can then be added together for an
overall MSS. Regardless of the approach used, both the
M-CASS and MSS demonstrate high reliability and in-
ternal consistency, as well as excellent inter-observer
reliability in evaluating septic animals. Moreover, the
findings of our study corroborate the observations of
Huet et al., suggesting that a clinical scoring system of-
fers an effective surrogate end point that is more ethic-
ally acceptable than death [8,15].
Because the MSS is based on simple observation, it
may be easily implemented in any laboratory that utilizes
a mouse model of sepsis. Moreover, it is also fully com-
patible with any investigative timeline because of its
non-invasive nature. Other methods to evaluate sepsis
severity in mouse models, including arterial pressure
monitoring, serum biochemistry assays, and cytokine ar-
rays can be difficult to perform in small animals. In
addition, only a limited amount of blood can be sampled
from septic mice without compromising the health of
the animal, necessitating the sacrifice of a large number
of animals to perform adequate analyses. Death, how-
ever, is not an acceptable endpoint for animal models of
sepsis at many institutions [8]; therefore, investigators
must carefully design experiments to balance the accur-
ate collection of data while minimizing animal suffering
[5,6,8,15]. Since the criteria for euthanasia may vary widely
and depend on the subjective evaluation by the investiga-
tor, adoption of our scoring system will provide a uniform
approach to addressing criteria for euthanasia. The MSS
may also be used in microbe-specific models of sepsis, al-
though calibration of the scoring system will be necessary
to optimize sensitivity and specificity. This would be espe-
cially important for models that require post-surgical re-
covery from anaesthesia [12,13], which may confound
early measures of activity and level of consciousness. As
animal models continue to be refined in order to more
closely mimic the human condition, the MSS may remain
effective and applicable because of its emphasis on clinical
characteristics.
We elected to use the FIP model to test the validity of
the MSS because it was easy to standardize and conduct
in a controlled setting, given that multiple operators with
varying levels of surgical expertise were conducting the ex-
periments in three different laboratories. Outcomes in our
model could be changed simply by varying the concentra-
tion of feces in solution, unlike the CLP model, which re-
quires changes to the surgical protocol (such as needle
size, number of punctures, and manual extrusion of cecal
contents) to alter disease outcomes [10]. The need for sur-
gical anesthesia is also obviated with the FIP model, re-
moving another confounding factor that can affect animalbehaviour in the immediate post-surgical period [22]. En-
suring that our FIP model was successfully mimicking the
pro-inflammatory response seen in clinical sepsis [23], we
consistently demonstrated bacterial growth in every major
organ in septic mice, with similar tissue CFUs in inde-
pendently performed experiments. While this study was
limited by the inability to culture and identify strictly an-
aerobic microorganisms, we observed colonies that varied
in size, shape, and color, confirming the polymicrobial na-
ture of the infection. The biochemistry data, with the clear
evidence of progressive hepatic dysfunction and failure,
and the overwhelming cytokine dysfunction, likely contrib-
uted to the morbidity and mortality of our mice.
The characteristic cytokine markers of sepsis [24,25],
including IL-1β, IL-6, IL-10 and TNF-α, increased sig-
nificantly during the experimental timeline. For what we
believe is the first time, however, we also demonstrate
that levels of eotaxin, IL-5, IL-15, M-CSF, MIG, MIP-1α,
MIP-1β, and MIP-2 rise significantly during sepsis. Eotaxin
is associated with eosinophil recruitment and function
[26], and also inhibits neutrophil recruitment during the
acute inflammatory phase of sepsis. IL-15, M-CSF, MIG,
MIP-1α, MIP-1β and MIP-2 promote cellular differen-
tiation, activity, survival, recruitment and chemotaxis
[27-29], confirming the complexity of the dysregulated
immune response during sepsis. In addition, the levels
of certain pro-inflammatory cytokines (eotaxin, IL-6,
G-CSF, M-CSF, MIG, and RANTES) correlate strongly
with the MSS, confirming that the score reflects the se-
verity of the septic insult. Some pro-inflammatory markers
such as TNF-α and IL-1β did not demonstrate correlation
with the MSS, although they were significantly elevated in
septic mice compared to sham-treated mice; this may have
been due to the early elevation of these markers during the
experimental timeline, or due to the variability from pool-
ing cytokine data from multiple independently-performed
experiments.
Interestingly, the histological changes we noted in or-
gans from septic mice were subtle despite the obvious
clinical severity of the animals, an observation that cor-
relates with other studies [30,31] utilizing both FIP and
CLP models. In their CLP model, for example, Doi et al.
observed renal tubular damage mainly consisting of tubu-
lar vacuolization [32,33] but no changes in the lung, liver,
or intestinal tract [31]; Fisher et al. did not observe signifi-
cant changes in the lungs or kidneys of FIP mice [30].
Despite the significant intestinal distension seen consist-
ently in septic mice within our study, histology of the
gastrointestinal tract manifested subtle changes that have
been described in other sepsis models, including the loss
of glandular structure and intestinal epithelial villi, edema
of the lamina propria, capillary hemorrhage, ulceration
and apoptosis [34]. Apoptosis was also most evident in
the spleen, as confirmed by TUNEL staining, and likely
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the CLP model by Hotchkiss et al. [35,36]. These results
corroborate human studies indicating that apoptotic fac-
tors may be early biomarkers of sepsis that modulate
lymphocyte and monocyte activity [23,36]. In the lungs,
we observed minimal extravasation of red cells,but little
accumulation of inflammatory cells into the air spaces as
described by Zingarelli et al. [37].
Conclusion
In conclusion, we present a validated MSS that can be ap-
plied reliably, consistently, and independently in an animal
model of sepsis, with high specificity and sensitivity for
predicting the onset of severe sepsis and death during the
experimental timeline. Utilization of this scoring system
may not be limited to the fecal-induced peritonitis model
used in this study, and may allow for a standardized
method of describing disease outcomes across various ex-
perimental animal models of sepsis. Most importantly, the
assessment of clinical status in septic animals may be an
ethically acceptable alternative to death as an endpoint in
animal models of sepsis.
Additional files
Additional file 1: Figure S1. Macroscopic intra-abdominal view of control
(left) and 90 mg/mL FIP mouse (right) at 24 h reveals significant intestinal
distension in the latter (size bar, 1 cm).
Additional file 2: Table S1. Changes in concentrations of chemokines
and cytokines in sham- and 90 mg/mL FS-treated mice with FIP.
Competing interests
The authors do not have any actual or potential conflicts of interest or
competing financial interests to declare.
Author contributions
BS and RVA designed and conducted the experiments, performed data
analysis, and drafted the manuscript. SXX and MD conducted experiments,
and assisted with data analysis. SXX, SMMH, JKM, and TM provided critical
revisions of the manuscript for important intellectual content. All authors
read and approved the final version of this manuscript.
Acknowledgements
The authors would like to acknowledge and thank Kevin Gilmore for helping
to prepare some of the tissue slides for histology, and Dr. Aaron Haig
(Department of Pathology, Western University, London, Canada) for
assistance with interpreting tissue histopathology. This work was funded by
operating grants from the Department of Surgery (to B.S. and T.M.), and
Canadian Institutes of Health Research (CIHR) to J.K.M. (MOP-64176) and S.M.
M.H (MOP-130465). R.V.A. is supported by the Royal College of Surgeons and
Physicians of Canada (RCPSC) Clinical Investigator Program (Western
University, London, Canada) and the CIHR Canada Graduate Scholarship,
while S.X.X is supported by an Ontario Graduate Scholarship.
Author details
1Division of General Surgery, Department of Surgery, Schulich School of
Medicine and Dentistry, Western University, London, Ontario, Canada.
2Department of Microbiology and Immunology, Schulich School of Medicine
and Dentistry, Western University, London, Ontario, Canada. 3Division of
Critical Care, Department of Medicine, Schulich School of Medicine and
Dentistry, Western University, London, Ontario, Canada. 4Division of GeneralSurgery and Critical Care, Room A8-124, London Health Sciences
Centre-University Hospital, 339 Windermere Road, London, ON N6A 5A5, Canada.
Received: 26 February 2014 Accepted: 9 April 2014
Published: 12 April 2014
References
1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM,
Sibbald WJ: Definitions for sepsis and organ failure and guidelines for
the use of innovative therapies in sepsis. The ACCP/SCCM Consensus
Conference Committee. American College of Chest Physicians/Society of
Critical Care Medicine. 1992. Chest 2009, 136:e28.
2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in
the United States from 1979 through 2000. New Engl J Med 2003,
348:1546–1554.
3. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R,
Carlet J, Le Gall JR, Payen D: Sepsis in European intensive care units:
results of the SOAP study. Crit Care Med 2006, 34:344–353.
4. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM,
Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis
Definitions Conference. Crit Care Med 2003, 31:1250–1256.
5. Buras JA, Holzmann B, Sitkovsky M: Animal models of sepsis: setting the
stage. Nat Rev Drug Discov 2005, 4:854–865.
6. Marshall JC: Such stuff as dreams are made on: mediator-directed
therapy in sepsis. Nat Rev Drug Discov 2003, 2:391–405.
7. Esmon CT: Why do animal models (sometimes) fail to mimic human
sepsis? Crit Care Med 2004, 32:S219–222.
8. Nemzek JA, Hugunin KM, Opp MR: Modeling sepsis in the laboratory:
merging sound science with animal well-being. Comp Med 2008,
58:120–128.
9. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R,
Lipman J, Gomersall C, Sakr Y, Reinhart K: International study of the
prevalence and outcomes of infection in intensive care units. J Am Med
Assoc 2009, 302:2323–2329.
10. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW, Bland KI 3rd,
Chaudry IH: Cecal ligation and puncture. Shock (Augusta, Ga) 2005,
24(1):52–57.
11. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock: a review of
laboratory models and a proposal. J Surg Res 1980, 29:189–201.
12. Maier S, Traeger T, Entleutner M, Westerholt A, Kleist B, Huser N, Holzmann B,
Stier A, Pfeffer K, Heidecke CD: Cecal ligation and puncture versus colon
ascendens stent peritonitis: two distinct animal models for polymicrobial
sepsis. Shock (Augusta, Ga) 2004, 21:505–511.
13. Dejager L, Pinheiro I, Dejonckheere E, Libert C: Cecal ligation and puncture:
the gold standard model for polymicrobial sepsis? Trends Microbiol 2011,
19:198–208.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of
disease classification system. Crit Care Med 1985, 13:818–829.
15. Huet O, Ramsey D, Miljavec S, Jenney A, Aubron C, Aprico A, Stefanovic N,
Balkau B, Head GA, de Haan JB, Chin-Dusting JP: Ensuring animal welfare
while meeting scientific aims using a murine pneumonia model of septic
shock. Shock (Augusta, Ga) 2013, 39:488–494.
16. Langford DJ, Bailey AL, Chanda ML, Clarke SE, Drummond TE, Echols S, Glick S,
Ingrao J, Klassen-Ross T, Lacroix-Fralish ML, Matsumiya L, Sorge RE, Sotocinal SG,
Tabaka JM, Wong D, van den Maagdenberg AM, Ferrari MD, Craig KD, Mogil JS:
Coding of facial expressions of pain in the laboratory mouse. Nature methods
2010, 7:447–449.
17. Hyde SR, Stith RD, McCallum RE: Mortality and bacteriology of sepsis
following cecal ligation and puncture in aged mice. Infect Immun 1990,
58:619–624.
18. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell
death in situ via specific labeling of nuclear DNA fragmentation. J Cell
Biol 1992, 119:493–501.
19. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver
operating characteristic (ROC) curve. Radiology 1982, 143:29–36.
20. Youden WJ: Index for rating diagnostic tests. Cancer 1950, 3:32–35.
21. Marshall JC, Reinhart K: Biomarkers of sepsis. Crit Care Med 2009,
37:2290–2298.
22. Lee SW, Feingold DL, Carter JJ, Zhai C, Stapleton G, Gleason N, Whelan RL:
Peritoneal macrophage and blood monocyte functions after open and
laparoscopic-assisted cecectomy in rats. Surg Endosc 2003, 17:1996–2002.
Shrum et al. BMC Research Notes 2014, 7:233 Page 11 of 11
http://www.biomedcentral.com/1756-0500/7/23323. Otto GP, Busch M, Sossdorf M, Claus RA: Impact of sepsis-associated
cytokine storm on plasma NGAL during acute kidney injury in a model
of polymicrobial sepsis. Critical care (London, England) 2013, 17:419.
24. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis.
New Engl J Med 2003, 348:138–150.
25. Hotchkiss RS, Opal S: Immunotherapy for sepsis–a new approach against
an ancient foe. New Engl J Med 2010, 363:87–89.
26. Linch SN, Danielson ET, Kelly AM, Tamakawa RA, Lee JJ, Gold JA: Interleukin
5 is protective during sepsis in an eosinophil-independent manner.
Am J Respir Crit Care Med 2012, 186:246–254.
27. Castillo EF, Schluns KS: Regulating the immune system via IL-15
transpresentation. Cytokine 2012, 59:479–490.
28. Jinquan T, Jing C, Jacobi HH, Reimert CM, Millner A, Quan S, Hansen JB,
Dissing S, Malling HJ, Skov PS, Poulsen LK: CXCR3 expression and
activation of eosinophils: role of IFN-gamma-inducible protein-10 and
monokine induced by IFN-gamma. J Immunol (Baltimore, Md: 1950) 2000,
165:1548–1556.
29. Driscoll KE: Macrophage inflammatory proteins: biology and role in
pulmonary inflammation. Exp Lung Res 1994, 20:473–490.
30. Fisher BJ, Kraskauskas D, Martin EJ, Farkas D, Puri P, Massey HD, Idowu MO,
Brophy DF, Voelkel NF, Fowler AA, Natarajan R: Attenuation of sepsis-
induced organ injury in mice by vitamin C. JPEN J Parenter Enteral Nutr
2013, Aug 5.
31. Doi K, Leelahavanichkul A, Hu X, Sidransky KL, Zhou H, Qin Y, Eisner C,
Schnermann J, Yuen PS, Star RA: Pre-existing renal disease promotes
sepsis-induced acute kidney injury and worsens outcome. Kidney Int
2008, 74:1017–1025.
32. Miyaji T, Hu X, Yuen PS, Muramatsu Y, Iyer S, Hewitt SM, Star RA: Ethyl
pyruvate decreases sepsis-induced acute renal failure and multiple
organ damage in aged mice. Kidney Int 2003, 64:1620–1631.
33. Yasuda H, Yuen PS, Hu X, Zhou H, Star RA: Simvastatin improves sepsis-
induced mortality and acute kidney injury via renal vascular effects.
Kidney Int 2006, 69:1535–1542.
34. Zhang Y, Li M, Meng M, Qin C: Effect of ethyl pyruvate on physical and
immunological barriers of the small intestine in a rat model of sepsis.
J Trauma 2009, 66:1355–1364.
35. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM,
Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and
multiple organ dysfunction. Crit Care Med 1999, 27:1230–1251.
36. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, Chang KC,
Osborne DF, Freeman BD, Cobb JP, Buchman TG, Karl IE: Sepsis-induced
apoptosis causes progressive profound depletion of B and CD4+ T
lymphocytes in humans. J Immunol (Baltimore, Md : 1950) 2001,
166:6952–6963.
37. Zingarelli B, Piraino G, Hake PW, O'Connor M, Denenberg A, Fan H, Cook JA:
Peroxisome proliferator-activated receptor {delta} regulates inflammation
via NF-{kappa}B signaling in polymicrobial sepsis. Am J Pathol 2010,
177:1834–1847.
doi:10.1186/1756-0500-7-233
Cite this article as: Shrum et al.: A robust scoring system to evaluate
sepsis severity in an animal model. BMC Research Notes 2014 7:233.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
